Unitree's $4,370 humanoid robot is for sale on AliExpress. It cannot hold a cup of coffee.
The R1, a roughly 123-centimeter-tall humanoid from Unitree, a Hangzhou-based robotics company founded in 2016 by then-26-year-old Wang Xingxing, went on sale internationally this week starting at roughly $4,370, according to the South China Morning Post. It tips the scales at about 27 to 29 kilograms depending on configuration. It can do cartwheels, lie down, stand up, and run downhill. It cannot grip a door handle or pick up a water bottle. It has no articulated fingers and its motors generate limited torque, Wired reported. What it is, according to every major review and Unitree's own product materials, is a research platform: a machine designed for university labs and engineering teams to train AI models for robot control, not a domestic servant or factory worker.
The customer base makes this clearer. Around 70% of Unitree's humanoid shipments in 2025 went to universities and research institutions, according to the company. The remaining 30% went to undisclosed commercial customers. Unitree offers an EDU variant for roughly $10,000 with additional computing power and optional articulated hands, while the base R1 starts at $4,900, according to robotics site Botinfo.ai — a price that fits inside most university grant budgets.
This is not a mass-market consumer product. It is a piece of laboratory equipment for teams building the brain that will eventually run a robot with hands.
The price story is real but incomplete. The cost reduction from roughly $5,900 last summer to $4,370 today reflects genuine supply chain localization: over 80% of Unitree's components are sourced within China, the company said, and that proximity is what enables sub-$5,000 pricing. "Cheapest humanoid robot ever" is a fact. It is also a frame that obscures what the product actually is.
Wang Xingxing, Unitree's founder and CEO, set a 2026 shipment target of 10,000 to 20,000 units. In 2025, the company shipped more than 5,500 humanoid robots. For context: Tesla, Figure AI, and Agility Robotics each shipped roughly 150 humanoids last year, according to Interesting Engineering. Unitree's volume is in a different category entirely. TrendForce projects Unitree will account for nearly half of China's total humanoid robot production in 2026, with competitor Agibot at roughly 30%, Interesting Engineering reported.
That scale is the backdrop for Unitree's Shanghai STAR Market IPO filing, which seeks to raise approximately 4.2 billion yuan, or about $610 million. The IPO prospectus, reviewed by Reuters, put Unitree's 2025 global market share at 32.4% with 5,500 units shipped. The documents frame the company as the world's leading humanoid robot manufacturer by volume.
The international pricing question remains open. Unitree has not disclosed what the R1 will cost outside China, according to the South China Morning Post. The AliExpress listing shows the China price of 29,900 yuan. Whether that number travels is a meaningful open question for the universities and research institutions outside China that currently represent the R1's core market.
What the R1 actually does well is reveal the gap between robot hardware and robot intelligence. The machine is physically capable — it can navigate uneven terrain, recover from falls, and perform dynamic whole-body movements that would have been a research paper five years ago. The part that isn't there yet is the brain. Running a humanoid reliably in an unstructured environment, handling the thousand-edge cases that a domestic task requires, is still an unsolved problem. Unitree is selling the hardware; the software is the customer's problem.
Chinese robotics companies have generally followed a hardware-first model: build reliable, inexpensive hardware at volume and let the software ecosystem develop use cases. Whether that path produces a commercially viable domestic robot in three years or ten is the question Unitree's IPO investors are betting on.
The cartwheels are genuinely impressive. The hands are not there yet. That is the entire story.
